These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36122348)

  • 41. Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.
    Hou J; Zou Q; Wang Y; Gao Q; Yao W; Yao Q; Zhang J
    J Biomol Struct Dyn; 2019 Aug; 37(12):3135-3149. PubMed ID: 30079817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of Synthetic Matrix Metalloproteinase Inhibitors by Fluorogenic Substrate Assay.
    Lively TJ; Bosco DB; Khamis ZI; Sang QX
    Methods Mol Biol; 2016; 1406():161-70. PubMed ID: 26820953
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Marine pharmacology: therapeutic targeting of matrix metalloproteinases in neuroinflammation.
    Gentile E; Liuzzi GM
    Drug Discov Today; 2017 Feb; 22(2):299-313. PubMed ID: 27697495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases.
    Fields GB
    Front Immunol; 2019; 10():1278. PubMed ID: 31214203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Novel Natural Product Inhibitors against Matrix Metalloproteinase 9 Using Quantum Mechanical Fragment Molecular Orbital-Based Virtual Screening Methods.
    Lim H; Hong H; Hwang S; Kim SJ; Seo SY; No KT
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Matrix metalloproteinase inhibitors based on the 3-mercaptopyrrolidine core.
    Jin Y; Roycik MD; Bosco DB; Cao Q; Constantino MH; Schwartz MA; Sang QX
    J Med Chem; 2013 Jun; 56(11):4357-73. PubMed ID: 23631440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of tumour cell apoptosis by matrix metalloproteinase inhibitors: new tricks from a (not so) old drug.
    Mitsiades N; Poulaki V; Mitsiades CS; Anderson KC
    Expert Opin Investig Drugs; 2001 Jun; 10(6):1075-84. PubMed ID: 11772236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
    Pavlaki M; Zucker S
    Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Matrix metalloproteinases participate in osteosarcoma invasion.
    Bjørnland K; Flatmark K; Pettersen S; Aaasen AO; Fodstad O; Maelandsmo GM
    J Surg Res; 2005 Aug; 127(2):151-6. PubMed ID: 16083752
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
    Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.
    Adhikari N; Halder AK; Mallick S; Saha A; Saha KD; Jha T
    Bioorg Med Chem; 2016 Sep; 24(18):4291-4309. PubMed ID: 27452283
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
    Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
    Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth.
    Suojanen J; Salo T; Koivunen E; Sorsa T; Pirilä E
    Cancer Biol Ther; 2009 Dec; 8(24):2362-70. PubMed ID: 19855192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteins in Soy Might Have a Higher Role in Cancer Prevention than Previously Expected: Soybean Protein Fractions Are More Effective MMP-9 Inhibitors Than Non-Protein Fractions, Even in Cooked Seeds.
    Lima A; Oliveira J; Saúde F; Mota J; Ferreira RB
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264435
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Natural products as a gold mine for selective matrix metalloproteinases inhibitors.
    Wang L; Li X; Zhang S; Lu W; Liao S; Liu X; Shan L; Shen X; Jiang H; Zhang W; Huang J; Li H
    Bioorg Med Chem; 2012 Jul; 20(13):4164-71. PubMed ID: 22658537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The past, present and future perspectives of matrix metalloproteinase inhibitors.
    Li K; Tay FR; Yiu CKY
    Pharmacol Ther; 2020 Mar; 207():107465. PubMed ID: 31863819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of matrix metalloproteinases-2, -8, -13, -26, and tissue inhibitors of metalloproteinase-1 in human osteosarcoma.
    Korpi JT; Hagström J; Lehtonen N; Parkkinen J; Sorsa T; Salo T; Laitinen M
    Surg Oncol; 2011 Mar; 20(1):e18-22. PubMed ID: 20880700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts.
    Dickens DS; Cripe TP
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):709-14. PubMed ID: 12972806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.